Average Co-Inventor Count = 6.72
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (30 from 2,405 patents)
2. Msd R&d (china) Co., Ltd. (3 from 10 patents)
3. Msd Italia S.r.l. (2 from 7 patents)
4. Merck + Co., Inc. (1 from 4,770 patents)
5. Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa (1 from 47 patents)
6. Merck Msd (r&d) China Co., Ltd. (1 from 1 patent)
7. Merck Canada Inc. (40 patents)
8. Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.r.l. (4 patents)
9. Msd R&d Co., Ltd. (0 patent)
31 patents:
1. 12331018 - Pyrrolidine orexin receptor agonists
2. 12312332 - Heteroaryl pyrrolidine and piperidine orexin receptor agonists
3. 11826375 - Phosphinic amide prodrugs of tenofovir
4. 11680060 - Bicycloheptane pyrrolidine orexin receptor agonists
5. 11655216 - Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, compositions, and their use
6. 11339156 - 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor
7. 11149036 - 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor
8. 11098029 - 5-alkyl pyrrolidine orexin receptor agonists
9. 10981902 - 5-(pyridin-3-yl)oxazole allosteric modulators of the M4 muscarinic acetylcholine receptor
10. 10961215 - N-aryl and N-heteroaryl piperidine derivatives as liver X receptor beta agonists, compositions, and their use
11. 10933056 - 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor
12. 10894775 - Piperidine derivatives as liver X receptor beta agonists, compositions, and their use
13. 10752587 - Homobispiperidinyl derivatives as liver X receptor beta agonists, compositions and their use
14. 10512638 - 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor
15. 10239849 - Cyanopyridine derivatives as liver X receptor beta agonists, compositions, and their use